17β-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss

Neurobiology of Disease

Volumn 39, Issue 2, 2010, Pages 127-137

  Taylor, Lorelei C ^a,b   Puranam, Kasturi ^b   Gilmore, Wendy ^c   Ting, Jenny P Y ^a,b   Matsushima, Glenn K ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

17 estradiol; Cuprizone; Demyelination; E2; Estrogen; Microglia; Myelin; Oligodendrocyte; TNF ; Tumor necrosis factor alpha

Indexed keywords

CUPRIZONE; ESTRADIOL; MESSENGER RNA; MYELIN; PLACEBO; SOMATOMEDIN C; TOXIN; TUMOR NECROSIS FACTOR ALPHA; ANTIGEN; CHONDROITIN SULFATE PROTEOGLYCAN 4; DIAGNOSTIC AGENT; ESTROGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE TRANSFERASE; INDOLE DERIVATIVE; LUXOL FAST BLUE MBS; MONOAMINE OXIDASE INHIBITOR; PERIODIC ACID; PLANT LECTIN; PROTEOGLYCAN; RICINUS COMMUNIS AGGLUTININ 1; RICINUS COMMUNIS AGGLUTININ-1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL DEATH; CELL LOSS; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; GENE EXPRESSION; GLIOSIS; MALE; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REMYELINIZATION; STEM CELL; ANIMAL; BLOOD; C57BL MOUSE; CELL COUNT; CHEMICALLY INDUCED DISORDER; DEMYELINATING DISEASE; DISEASE MODEL; DRUG EFFECT; DRUG INTERACTION; GENE EXPRESSION REGULATION; GENETICS; MACROPHAGE; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIGENS; CELL COUNT; CUPRIZONE; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; ESTRADIOL; ESTROGENS; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE TRANSFERASE; INDOLES; INSULIN-LIKE GROWTH FACTOR I; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; MONOAMINE OXIDASE INHIBITORS; OLIGODENDROGLIA; PERIODIC ACID; PLANT LECTINS; PROTEOGLYCANS; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953703128     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2010.03.016     Document Type: Article

References (73)

1. Acs P., Kipp M., Norkute A., Johann S., Clarner T., Braun A., Berente Z., Komoly S., Beyer C. 17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice. Glia 2009, 57(8):807-814.
2. Arnett H.A., Mason J., Marino M., Suzuki K., Matsushima G.K., Ting J.P. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 2001, 4(11):1116-1122.
3. Arnett H.A., Hellendall R.P., Matsushima G.K., Suzuki K., Laubach V.E., Sherman P., Ting J.P. The protective role of nitric oxide in a neurotoxicant-induced demyelinating model. J Immunol 2002, 168(1):427-433.
4. Barres B.A., Jacobson M.D., Schmid R., Sendtner M., Raff M.C. Does oligodendrocyte survival depend on axons?. Curr. Biol. 1993, 3(8):489-497.
5. Barreto G., Veiga S., Azcoitia I., Garcia-Segura L.M., Garcia-Ovejero D. Testosterone decreases reactive astroglia and reactive microglia after brain injury in male rats: role of its metabolites, oestradiol and dihydrotestosterone. Eur. J. NeuroSci. 2007, 25(10):3039-3046.
6. Bebo B.F., Fyfe-Johnson A., Adlard K., Beam A.G., Vandenbark A.A., Offner H. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J Immunol 2001, 166(3):2080-2089.
7. Behl C., Moosmann B. Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach. Free Radic. Biol. Med. 2002, 33(2):182-191.
8. Borski R.J., Tsai W., DeMott-Friberg R., Barkan A.L. Regulation of somatic growth and the somatotropic axis by gonadal steroids: primary effect on insulin-like growth factor I gene expression and secretion. Endocrinology 1996, 137(8):3253-3259.
9. Bruce-Keller A.J., Keeling J.L., Keller J.N., Huang F.F., Camondola S., Mattson M.P. Antiinflammatory effects of estrogen on microglial activation. Endocrinology 2000, 141(10):3646-3656.
10. Cardona-Gomez G.P., Mendez P., DonCarlos L.L., Azcoitia I., Garcia-Segura L.M. Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection. Brain Res. Brain Res. Rev. 2001, 37(1-3):320-334.
11. Confavreux C., Vukusic S., Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003, 126(Pt 4):770-782.
12. Drew P.D., Chavis J.A. Female sex steroids: effects upon microglial cell activation. J Neuroimmunol 2000, 111(1-2):77-85.
13. Dubal D.B., Kashon M.L., Pettigrew L.C., Ren J.M., Finklestein S.P., Rau S.W., Wise P.M. Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 1998, 18(11):1253-1258.
14. Durrer S., Ehnes C., Fuetsch M., Maerkel K., Schlumpf M., Lichtensteiger W. Estrogen sensitivity of target genes and expression of nuclear receptor co-regulators in rat prostate after pre- and postnatal exposure to the ultraviolet filter 4-methylbenzylidene camphor. Environ. Health Perspect. 2007, 115(Suppl 1):42-50.
15. Elloso M.M., Phiel K., Henderson R.A., Harris H.A., Adelman S.J. Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands. J Endocrinol 2005, 185(2):243-252.
16. Foster H.L., Small J.D., Fox J.G. Normative Biology, Immunology and Husbandry of Laboratory Rodents 1983, Academic Press, Orlando.
17. Franklin GPaKBJ. 2001. the Mouse Brain in Stereotaxic Coordinates.
18. Garcia-Segura L.M., Wozniak A., Azcoitia I., Rodriguez J.R., Hutchison R.E., Hutchison J.B. Aromatase expression by astrocytes after brain injury: implications for local estrogen formation in brain repair. Neuroscience 1999, 89(2):567-578.
19. Garidou L., Laffont S., Douin-Echinard V., Coureau C., Krust A., Chambon P., Guery J.C. Estrogen receptor alpha signaling in inflammatory leukocytes is dispensable for 17beta-estradiol-mediated inhibition of experimental autoimmune encephalomyelitis. J Immunol 2004, 173(4):2435-2442.
20. Gerstner B., Sifringer M., Dzietko M., Schuller A., Lee J., Simons S., Obladen M., Volpe J.J., Rosenberg P.A., Felderhoff-Mueser U. Estradiol attenuates hyperoxia-induced cell death in the developing white matter. Ann. Neurol. 2007, 61(6):562-573.
21. Ghoumari A.M., Ibanez C., El-Etr M., Leclerc P., Eychenne B., O'Malley B.W., Baulieu E.E., Schumacher M. Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J Neurochem 2003, 86(4):848-859.
22. Hiremath M.M., Saito Y., Knapp G.W., Ting J.P., Suzuki K., Matsushima G.K. Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. J Neuroimmunol 1998, 92(1-2):38-49.
23. Hiremath M.M., Chen V.S., Suzuki K., Ting J.P.-Y., Matsushima G.K. MHC class II exacerbates demyelination in vivo independently of T cells. J. Neuroimmunol. 2008, 203(1):22-23.
24. Hoffman G.E., Le W.W., Murphy A.Z., Koski C.L. Divergent effects of ovarian steroids on neuronal survival during experimental allergic encephalitis in Lewis rats. Exp. Neurol. 2001, 171(2):272-284.
25. Hoffman G.E., Merchenthaler I., Zup S.L. Neuroprotection by ovarian hormones in animal models of neurological disease. Endocr. 2006, 29(2):217-231.
26. Iocca H.A., Plant S.R., Wang Y., Runkel L., O'Connor B.P., Lundsmith E.T., Hahm K., van Deventer H.W., Burkly L.C., Ting J.P. TNF superfamily member TWEAK exacerbates inflammation and demyelination in the cuprizone-induced model. J Neuroimmunol 2008, 194(1-2):97-106.
27. Irvine K.A., Blakemore W.F. Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice. J Neuroimmunol 2006, 175(1-2):69-76.
28. Ito A., Bebo B.F., Matejuk A., Zamora A., Silverman M., Fyfe-Johnson A., Offner H. Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J Immunol 2001, 167(1):542-552.
29. Jung-Testas I., Renoir M., Bugnard H., Greene G.L., Baulieu E.E. Demonstration of steroid hormone receptors and steroid action in primary cultures of rat glial cells. J Steroid Biochem Mol Biol 1992, 41(3-8):621-631.
30. Kim S., Liva S.M., Dalal M.A., Verity M.A., Voskuhl R.R. Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. Neurology 1999, 52(6):1230-1238.
31. Komoly S., Hudson L.D., Webster H.D., Bondy C.A. Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination. Proc Natl Acad Sci U S A 1992, 89(5):1894-1898.
32. Lin C.L., Dumont A.S., Su Y.F., Tsai Y.J., Huang J.H., Chang K.P., Howng S.L., Kwan A.L., Kassell N.F., Kao C.H. Attenuation of cerebral vasospasm and secondary injury by 17beta-estradiol following experimental subarachnoid hemorrhage. J Neurosurg 2009, 110(3):457-461.
33. Linares D., Taconis M., Mana P., Correcha M., Fordham S., Staykova M., Willenborg D.O. Neuronal nitric oxide synthase plays a key role in CNS demyelination. J Neurosci 2006, 26(49):12672-12681.
34. Marin-Husstege M., Muggironi M., Raban D., Skoff R.P., Casaccia-Bonnefil P. Oligodendrocyte progenitor proliferation and maturation is differentially regulated by male and female sex steroid hormones. Dev. Neurosci. 2004, 26(2-4):245-254.
35. Mason J.L., Jones J.J., Taniike M., Morell P., Suzuki K., Matsushima G.K. Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. J Neurosci Res 2000, 61(3):251-262.
36. Mason J.L., Ye P., Suzuki K., D'Ercole A.J., Matsushima G.K. Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J Neurosci 2000, 20(15):5703-5708.
37. Mason J.L., Langaman C., Morell P., Suzuki K., Matsushima G.K. Episodic demyelination and subsequent remyelination within the murine central nervous system: changes in axonal calibre. Neuropathol. Appl. Neurobiol. 2001, 27(1):50-58.
38. Mason J.L., Suzuki K., Chaplin D.D., Matsushima G.K. Interleukin-1beta promotes repair of the CNS. J Neurosci 2001, 21(18):7046-7052.
39. Mason J.L., Xuan S., Dragatsis I., Efstratiadis A., Goldman J.E. Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination. J Neurosci 2003, 23(20):7710-7718.
40. Matejuk A., Adlard K., Zamora A., Silverman M., Vandenbark A.A., Offner H. 17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis. J Neurosci Res 2001, 65(6):529-542.
41. Matsushima G.K., Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 2001, 11(1):107-116.
42. McMahon E.J., Suzuki K., Matsushima G.K. Peripheral macrophage recruitment in cuprizone-induced CNS demyelination despite an intact blood-brain barrier. J Neuroimmunol 2002, 130(1-2):32-45.
43. Mendez P., Azcoitia I., Garcia-Segura L.M. Estrogen receptor alpha forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and phosphatidylinositol 3-kinase in the adult rat brain. Brain Res. Mol. Brain Res. 2003, 112(1-2):170-176.
44. Mendez P., Cardona-Gomez G.P., Garcia-Segura L.M. Interactions of insulin-like growth factor-I and estrogen in the brain. Adv. Exp. Med. Biol. 2005, 567:285-303.
45. Merchenthaler I., Lane M.V., Numan S., Dellovade T.L. Distribution of estrogen receptor alpha and beta in the mouse central nervous system: in vivo autoradiographic and immunocytochemical analyses. J Comp Neurol 2004, 473(2):270-291.
46. Michels K.M., Lee W.H., Seltzer A., Saavedra J.M., Bondy C.A. Up-regulation of pituitary [125I]insulin-like growth factor-I (IGF-I) binding and IGF binding protein-2 and IGF-I gene expression by estrogen. Endocrinology 1993, 132(1):23-29.
47. Milner T.A., McEwen B.S., Hayashi S., Li C.J., Reagan L.P., Alves S.E. Ultrastructural evidence that hippocampal alpha estrogen receptors are located at extranuclear sites. J Comp Neurol 2001, 429(3):355-371.
48. Milner T.A., Ayoola K., Drake C.T., Herrick S.P., Tabori N.E., McEwen B.S., Warrier S., Alves S.E. Ultrastructural localization of estrogen receptor beta immunoreactivity in the rat hippocampal formation. J Comp Neurol 2005, 491(2):81-95.
49. Mitra S.W., Hoskin E., Yudkovitz J., Pear L., Wilkinson H.A., Hayashi S., Pfaff D.W., Ogawa S., Rohrer S.P., Schaeffer J.M., McEwen B.S., Alves S.E. Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha. Endocrinology 2003, 144(5):2055-2067.
50. Morales L.B., Loo K.K., Liu H.B., Peterson C., Tiwari-Woodruff S., Voskuhl R.R. Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis. J Neurosci 2006, 26(25):6823-6833.
51. Morell P., Barrett C.V., Mason J.L., Toews A.D., Hostettler J.D., Knapp G.W., Matsushima G.K. Gene expression in brain during cuprizone-induced demyelination and remyelination. Mol. Cell. Neurosci. 1998, 12(4-5):220-227.
52. Murphy L.J., Murphy L.C., Friesen H.G. Estrogen induces insulin-like growth factor-I expression in the rat uterus. Mol. Endocrinol. 1987, 1(7):445-450.
53. Nishiyama A., Komitova M., Suzuki R., Zhu X. Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat Rev Neurosci 2009, 10(1):9-22.
54. Pasquini L.A., Calatayud C.A., Bertone Una A.L., Millet V., Pasquini J.M., Soto E.F. The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia. Neurochem. Res. 2007, 32(2):279-292.
55. Plant S.R., Arnett H.A., Ting J.P. Astroglial-derived lymphotoxin-alpha exacerbates inflammation and demyelination, but not remyelination. Glia 2005, 49(1):1-14.
56. Plant S.R., Iocca H.A., Wang Y., Thrash J.C., O'Connor B.P., Arnett H.A., Fu Y.X., Carson M.J., Ting J.P. Lymphotoxin beta receptor (Lt betaR): dual roles in demyelination and remyelination and successful therapeutic intervention using Lt betaR-Ig protein. J Neurosci 2007, 27(28):7429-7437.
57. Polanczyk M.J., Jones R.E., Subramanian S., Afentoulis M., Rich C., Zakroczymski M., Cooke P., Vandenbark A.A., Offner H. T lymphocytes do not directly mediate the protective effect of estrogen on experimental autoimmune encephalomyelitis. Am. J. Pathol. 2004, 165(6):2069-2077.
58. Pozzi S., Benedusi V., Maggi A., Vegeto E. Estrogen action in neuroprotection and brain inflammation. Ann. N. Y. Acad. Sci. 2006, 1089:302-323.
59. Probert L., Akassoglou K., Pasparakis M., Kontogeorgos G., Kollias G. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc Natl Acad Sci U S A 1995, 92(24):11294-11298.
60. Quesada A., Micevych P.E. Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions. J Neurosci Res 2004, 75(1):107-116.
61. Selvaraju R., Bernasconi L., Losberger C., Graber P., Kadi L., Avellana-Adalid V., Picard-Riera N., Van Evercooren A.B., Cirillo R., Kosco-Vilbois M., Feger G., Papoian R., Boschert U. Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro. Mol. Cell. Neurosci. 2004, 25(4):707-721.
62. Shingo A.S., Kito S. Estrogen induces insulin-like growth factor-1 mRNA expression in the immortalized hippocampal cell: determination by quantitative real-time polymerase chain reaction. Neurochem. Res. 2003, 28(9):1379-1383.
63. Sierra A., Gottfried-Blackmore A., Milner T.A., McEwen B.S., Bulloch K. Steroid hormone receptor expression and function in microglia. Glia 2008, 56(6):659-674.
64. Takao T., Flint N., Lee L., Ying X., Merrill J., Chandross K.J. 17beta-estradiol protects oligodendrocytes from cytotoxicity induced cell death. J Neurochem 2004, 89(3):660-673.
65. Tiwari-Woodruff S., Morales L.B., Lee R., Voskuhl R.R. Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. Proc Natl Acad Sci U S A 2007, 104(37):14813-14818.
66. Vegeto E., Bonincontro C., Pollio G., Sala A., Viappiani S., Nardi F., Brusadelli A., Viviani B., Ciana P., Maggi A. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci 2001, 21(6):1809-1818.
67. Vegeto E., Belcredito S., Etteri S., Ghisletti S., Brusadelli A., Meda C., Krust A., Dupont S., Ciana P., Chambon P., Maggi A. Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol. Proc Natl Acad Sci U S A 2003, 100(16):9614-9619.
68. Vegeto E., Belcredito S., Ghisletti S., Meda C., Etteri S., Maggi A. The endogenous estrogen status regulates microglia reactivity in animal models of neuroinflammation. Endocrinology 2006, 147(5):2263-2272.
69. Vegeto E., Benedusi V., Maggi A. Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases. Front. Neuroendocrinol. 2008, 29(4):507-519.
70. Wen Y., Yang S., Liu R., Perez E., Yi K.D., Koulen P., Simpkins J.W. Estrogen attenuates nuclear factor-kappa B activation induced by transient cerebral ischemia. Brain Res. 2004, 1008(2):147-154.
71. Ye P., D'Ercole A.J. Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-alpha-induced injury. Endocrinology 1999, 140(7):3063-3072.
72. Zhang Z., Cerghet M., Mullins C., Williamson M., Bessert D., Skoff R. Comparison of in vivo and in vitro subcellular localization of estrogen receptors alpha and beta in oligodendrocytes. J Neurochem 2004, 89(3):674-684.
73. Zhu X., Bergles D.E., Nishiyama A. NG2 cells generate both oligodendrocytes and gray matter astrocytes. Development 2008, 135(1):145-157.